Allogene Therapeutics, Inc. (ALLO) › Total LiabilitiesAllogene Therapeutics, Inc. (ALLO) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $2.0K2018: $70.69M2019: $88.78M2020: $148.21M2021: $125.63M2022: $154.70M2023: $130.60M2024: $126.53M2025: $123.36M$123.36M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$123.36M-2.5%2024$126.53M-3.1%2023$130.60M-15.6%2022$154.70M+23.1%2021$125.63M-15.2%2020$148.21M+66.9%2019$88.78M+25.6%2018$70.69M+3534450.0%2017$2.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share